|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06078 HYGEIA HEALTH
Nominal 
10.060 -0.220 (-2.140%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 1,961,022 | -1.439% | 4,008,832 | 4,446,120 | 4,076,680 | 3,195,648 |
| Cost of Sales | (1,423,846) | -2.542% | (2,985,356) | (3,116,647) | (2,790,428) | (2,167,095) |
| Gross Profit | 537,176 | 1.609% | 1,023,476 | 1,329,473 | 1,286,252 | 1,028,553 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (283,321) | (57,614) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 315,369 | 1.735% | 327,533 | 750,816 | 856,087 | 643,311 | |
| Taxation | (57,928) | -9.727% | (166,007) | (152,484) | (171,139) | (161,435) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (27) | -- | 3,000 | (71) | (2,020) | (5,092) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 257,414 | 4.188% | 164,526 | 598,261 | 682,928 | 476,784 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 24,971 | -27.593% | 65,892 | 70,328 | 33,017 | 23,510 |
| Depreciation & Amortisation | 152,310 | -2.047% | 303,888 | 295,125 | 210,542 | 153,181 |
| Directors' Emoluments | -- | -- | -- | 5,074 | 9,919 | 12,645 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 42.000 | 5.000% | 27.000 | 95.000 | 108.000 | 77.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 15.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | 19.481% |
| Cash flow per share ($) | -- | -- | 1.537 | 1.124 | 1.240 | 1.111 |
| NBV per share ($) | 11.418 | -- | 10.969 | 10.700 | 9.870 | 8.000 |
| Remarks: | Real time quote last updated: 10/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 257,414 |
| %Change | 4.188% |
| EPS / (LPS) | RMB 0.420 |
| NBV Per Share (¥) | RMB 11.418 |